Lifestyle, Exercise and Nutrition (LEAN) Study 2
The LEAN Study 2, sponsored by Yale University, investigates the efficacy and cost-effectiveness of a structured weight loss program versus usual care in breast cancer survivors. Given the rising prevalence of obesity and its association with poorer outcomes in breast cancer, this study addresses a significant unmet need in survivorship care. The findings could inform clinical guidelines and potentially lead to the development of commercial weight management programs tailored for this demographic. The market for obesity management solutions is substantial, with increasing demand for evidence-based interventions. Competitive implications include positioning against existing weight loss programs and potential partnerships with healthcare providers focused on cancer survivorship.
Indication: Breast Cancer
Modality: behavioral intervention
Target: Weight loss and associated metabolic markers in breast cancer survivors
Sponsor: Yale University
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jun 25, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Weight loss and associated metabolic markers in breast cancer survivors
View original source fields
Condition raw: Breast Cancer, Weight Loss
Condition normalized: Breast Cancer, Weight Loss
Modality raw: behavioral intervention
Modality normalized: behavioral intervention
Target raw: Weight loss and associated metabolic markers in breast cancer survivors
Target normalized: Weight loss and associated metabolic markers in breast cancer survivors